PHARMA-B2B- -Drugmax- 931029- Sehr gute News seht mal rein ! - 500 Beiträge pro Seite
eröffnet am 17.04.01 18:12:30 von
neuester Beitrag 23.04.01 07:59:00 von
neuester Beitrag 23.04.01 07:59:00 von
Beiträge: 2
ID: 382.937
ID: 382.937
Aufrufe heute: 0
Gesamt: 167
Gesamt: 167
Aktive User: 0
ISIN: US2622401048
Eine Perle wird geboren.
http://www.Drugmax.com/
Hier die letzten News
http://www.bigcharts.com/quickchart/quickchart.asp?symb=dmax…
CBS MarketWatch Headlines
Monday, April 17, 2000
DRUGMAX.COM PAYS $5.9 MLN IN CASH, STOCK, ASSUMED DEBT FOR VALLEY DRUG CO. 7:36 AM
DRUGMAX.COM SAYS VALLEY DRUG CO. PROFITABLE, HAD $50 MLN IN 1999 SALES 7:36 AM
News Headlines
Monday, April 16, 2001
Schneider Securities, Inc. (SSI) Initiates Coverage of Drugmax.com, Inc.; Drugmax.com, Inc. Rating: BUY; 12-18 Month Price Target - $12 Per Share - PRNewswire 10:48 AM
Thursday, February 15, 2001
DrugMax.com Reports Record Third Quarter Financial Results and Positive Cash Flow - BusinessWire 7:59 AM
Tuesday, November 14, 2000
DrugMax.com Reports Second Quarter Financial Results and a Positive Cash Flow Ahead of Schedule - BusinessWire 6:14 PM
Wednesday, November 01, 2000
Drugmax.com Announces Secondary Offering of Common Stock - BusinessWire 6:08 PM
Wednesday, September 20, 2000
Drugmax.com Joins Forces With Utendahl Capital Partners, L.P. - BusinessWire 8:00 AM
Tuesday, September 12, 2000
Drugmax.com President to Interview On ``The Inside Corner`` On RadioWallStreet.com - BusinessWire 10:12 AM
Thursday, August 10, 2000
Drugmax.com Launches Pharmaceutical Industry`s First ``Alternate Supply`` Electronic Exchange - BusinessWire
-------
Heute noch bei lächerliche 6$
Ziel: 12 bis 18$ Siehe letztes Rating.
Dies ist nur eine INFO
http://www.Drugmax.com/
Hier die letzten News
http://www.bigcharts.com/quickchart/quickchart.asp?symb=dmax…
CBS MarketWatch Headlines
Monday, April 17, 2000
DRUGMAX.COM PAYS $5.9 MLN IN CASH, STOCK, ASSUMED DEBT FOR VALLEY DRUG CO. 7:36 AM
DRUGMAX.COM SAYS VALLEY DRUG CO. PROFITABLE, HAD $50 MLN IN 1999 SALES 7:36 AM
News Headlines
Monday, April 16, 2001
Schneider Securities, Inc. (SSI) Initiates Coverage of Drugmax.com, Inc.; Drugmax.com, Inc. Rating: BUY; 12-18 Month Price Target - $12 Per Share - PRNewswire 10:48 AM
Thursday, February 15, 2001
DrugMax.com Reports Record Third Quarter Financial Results and Positive Cash Flow - BusinessWire 7:59 AM
Tuesday, November 14, 2000
DrugMax.com Reports Second Quarter Financial Results and a Positive Cash Flow Ahead of Schedule - BusinessWire 6:14 PM
Wednesday, November 01, 2000
Drugmax.com Announces Secondary Offering of Common Stock - BusinessWire 6:08 PM
Wednesday, September 20, 2000
Drugmax.com Joins Forces With Utendahl Capital Partners, L.P. - BusinessWire 8:00 AM
Tuesday, September 12, 2000
Drugmax.com President to Interview On ``The Inside Corner`` On RadioWallStreet.com - BusinessWire 10:12 AM
Thursday, August 10, 2000
Drugmax.com Launches Pharmaceutical Industry`s First ``Alternate Supply`` Electronic Exchange - BusinessWire
-------
Heute noch bei lächerliche 6$
Ziel: 12 bis 18$ Siehe letztes Rating.
Dies ist nur eine INFO
Sieht gut aus
Monday, April 16, 2001
Schneider Securities, Inc. (SSI) Initiates Coverage of Drugmax.com, Inc.; Drugmax.com, Inc. Rating: BUY; 12-18 Month Price Target - $12 Per Share - PRNewswire 10:48 AM
Thursday, February 15, 2001
DrugMax.com Reports Record Third Quarter Financial Results and Positive Cash Flow - BusinessWire 7:59 AM
Tuesday, November 14, 2000
DrugMax.com Reports Second Quarter Financial Results and a Positive Cash Flow Ahead of Schedule - BusinessWire
Monday, April 16, 2001
Schneider Securities, Inc. (SSI) Initiates Coverage of Drugmax.com, Inc.; Drugmax.com, Inc. Rating: BUY; 12-18 Month Price Target - $12 Per Share - PRNewswire 10:48 AM
Thursday, February 15, 2001
DrugMax.com Reports Record Third Quarter Financial Results and Positive Cash Flow - BusinessWire 7:59 AM
Tuesday, November 14, 2000
DrugMax.com Reports Second Quarter Financial Results and a Positive Cash Flow Ahead of Schedule - BusinessWire
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Investoren beobachten auch:
Wertpapier | Perf. % |
---|---|
+4,38 |
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
220 | ||
104 | ||
93 | ||
77 | ||
47 | ||
43 | ||
41 | ||
40 | ||
31 | ||
31 |